NEJM This Week — March 5, 2026 Podcast Por  capa

NEJM This Week — March 5, 2026

NEJM This Week — March 5, 2026

Ouça grátis

Ver detalhes do programa

OFERTA POR TEMPO LIMITADO: Apenas R$ 0,99/mês nos primeiros 3 meses

Renova automaticamente por R$ 19,90/mês após 3 meses

Sobre este título

This week, we explore a phase 3 trial of finerenone in type 1 diabetes and chronic kidney disease and guidance on timing of nonculprit-lesion PCI after STEMI. We cover an investigational therapy for Dravet syndrome and neoadjuvant treatment for high-risk intrahepatic cholangiocarcinoma. We review the effects of radiotherapy on normal tissue, a puzzling case of progressive neurologic decline after suspected foodborne illness, and Perspectives on private equity, the AHEAD model, and medical credit cards.
Ainda não há avaliações